Literature DB >> 28577289

Immunoglobulin-responsive chikungunya encephalitis: two case reports.

Stephanie Suzanne de O Scott1, Pedro Braga-Neto2,3, Lícia Pacheco Pereira4, Paulo Ribeiro Nóbrega4, Francisco de Assis Aquino Gondim2, Manoel Alves Sobreira-Neto2,5, Claudia Carvalho Mendes Schiavon4.   

Abstract

Chikungunya virus is an alphavirus transmitted by the mosquito Aedes, mainly Aedes aegypti and Aedes albopictus, that can cause acute illness, mostly self-limited, characterized by fever, maculopapular rash, and disabling polyarthritis/arthralgia, with an incubation period of 1 to 12 days. Chikungunya was largely regarded as a non-fatal and self-limited disease, but recently, serious cases have been reported including some with severe involvement of the nervous system, such as meningoencephalitis, myelitis, polyradiculitis, and polyradiculoneuropathy. In this report, we describe the clinical and laboratory findings of two patients with encephalitis associated with chikungunya in a northeastern city in Brazil, who exhibited a good outcome, with improvement after treatment with i.v. immunoglobulin (IVIg).

Entities:  

Keywords:  Chikungunya; Encephalitis; Immunoglobulin; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28577289     DOI: 10.1007/s13365-017-0535-y

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  14 in total

1.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

Review 2.  Chikungunya virus pathogenesis: From bedside to bench.

Authors:  Thérèse Couderc; Marc Lecuit
Journal:  Antiviral Res       Date:  2015-07-06       Impact factor: 5.970

3.  Chikungunya in Brazil: an emerging challenge.

Authors:  Maria Rita Donalisio; André Ricardo Ribas Freitas
Journal:  Rev Bras Epidemiol       Date:  2015-03-01

4.  Encephalitis caused by Chikungunya virus in a traveler from the Kingdom of Tonga.

Authors:  Joanna Nelson; Jesse J Waggoner; Malaya K Sahoo; Philip M Grant; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

Review 5.  Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus.

Authors:  Trina Das; Marie Christine Jaffar-Bandjee; Jean Jacques Hoarau; Pascale Krejbich Trotot; Melanie Denizot; Ghislaine Lee-Pat-Yuen; Renubala Sahoo; Pascale Guiraud; Duksha Ramful; Stephanie Robin; Jean Luc Alessandri; Bernard Alex Gauzere; Philippe Gasque
Journal:  Prog Neurobiol       Date:  2009-12-23       Impact factor: 11.685

6.  Multifaceted innate immune responses engaged by astrocytes, microglia and resident dendritic cells against Chikungunya neuroinfection.

Authors:  Trina Das; Jean Jacques Hoarau; Marie Christine Jaffar Bandjee; Marianne Maquart; Philippe Gasque
Journal:  J Gen Virol       Date:  2014-10-28       Impact factor: 3.891

7.  Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic.

Authors:  Alladi Mohan; D H N Kiran; I Chiranjeevi Manohar; D Prabath Kumar
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

8.  Severe manifestations of chikungunya virus in critically ill patients during the 2013-2014 Caribbean outbreak.

Authors:  Laura Crosby; Caroline Perreau; Benjamin Madeux; Jeanne Cossic; Christophe Armand; Cécile Herrmann-Storke; Fatiha Najioullah; Ruddy Valentino; Guillaume Thiéry
Journal:  Int J Infect Dis       Date:  2016-05-18       Impact factor: 3.623

9.  An animal model for studying the pathogenesis of chikungunya virus infection.

Authors:  Sarah A Ziegler; Liang Lu; Amelia P A Travassos da Rosa; Shu-Yuan Xiao; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2008-07       Impact factor: 2.345

10.  Chikungunya risk for Brazil.

Authors:  Raimunda do Socorro da Silva Azevedo; Consuelo Silva Oliveira; Pedro Fernando da Costa Vasconcelos
Journal:  Rev Saude Publica       Date:  2015-09-18       Impact factor: 2.106

View more
  6 in total

1.  Peripheral polyneuropathy associated with Chikungunya virus infection.

Authors:  Vanessa P Silva; Dacylla S Costa; Vania C C V L Carvalho; Tereza C C S Garcês; Emanuela L T Barros; Jefferson S Oliveira; Anna C T C Pereira; Gustavo P Ferreira
Journal:  J Neurovirol       Date:  2019-08-19       Impact factor: 3.739

2.  Cerebrospinal Fluid Immunoglobulins as Potential Biomarkers of Chikungunya Encephalitis.

Authors:  Marzia Puccioni-Sohler; Luiz Claudio Farias; Mauro Jorge Cabral-Castro; Mariano G Zalis; Rosangela S Kalil; Maria Cecília F Salgado
Journal:  Emerg Infect Dis       Date:  2018-05       Impact factor: 6.883

Review 3.  The neurological complications of chikungunya virus: A systematic review.

Authors:  Ravi Mehta; Patrick Gerardin; Carlos Alexandre Antunes de Brito; Cristiane Nascimento Soares; Maria Lucia Brito Ferreira; Tom Solomon
Journal:  Rev Med Virol       Date:  2018-04-19       Impact factor: 6.989

4.  Immunoglobulin Therapy in a Patient With Severe Chikungunya Fever and Vesiculobullous Lesions.

Authors:  Ana Isabel V Fernandes; Joelma R Souza; Adriano R Silva; Sara B S C Cruz; Lúcio R C Castellano
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

5.  NMDAR Encephalitis Associated With Acute Chikungunya Virus Infection: A New Trigger?

Authors:  Paulo Ribeiro Nóbrega; Norma Martins de Menezes Morais; Pedro Braga-Neto; Liziana Sofia da Silva Barros; Fernanda Paiva Pereira Honório; Alessandra Dellavance; Romana Hoftberger; Lívia Almeida Dutra
Journal:  Front Pediatr       Date:  2020-04-30       Impact factor: 3.418

Review 6.  Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.

Authors:  Tharmala Tharmalingam; Xiaobing Han; Ashley Wozniak; Laura Saward
Journal:  Hum Vaccin Immunother       Date:  2021-05-19       Impact factor: 4.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.